Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01189136 · ClinicalTrials.gov registry record · NA

Treatment for Acute Postoperative Voiding Dysfunction

A NA study, sponsored by Women and Infants Hospital of Rhode Island.

Completed
Registry status
NA
Development phase
84
Enrollment target

NCT01189136: Completed NA study, sponsored by Women and Infants Hospital of Rhode Island.

NCT01189136 is a NA study that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01189136, a NA study, has completed, sponsored by Women and Infants Hospital of Rhode Island.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target

Study Summary

If patients are unable to have their foley catheter removed because their bladder is not emptying well, they may be eligible for study participation. This study is designed to evaluate whether Posterior Tibial Nerve Stimulation is effective in improving bladdder function after surgery. Study participation is limited to one day.

Primary Outcome

Number of participants with persistent unsuccessful trial of void after the intervention

Interventions

  • OTHER Sham treatment
  • DEVICE PTNS Active Treatment

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2006-07
Est. Completion 2013-12
Phase NA

What the finished NCT01189136 record still lists

NCT01189136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Sham treatment is the first listed.

NCT01189136 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01189136 about?

NCT01189136 is a clinical study titled "Treatment for Acute Postoperative Voiding Dysfunction". If patients are unable to have their foley catheter removed because their bladder is not emptying well, they may be eligible for study participation. This study is designed to evaluate whether Posterior Tibial Nerve Stimulation is effective in improving bladdder function after surgery. Study partici...

What is the current status of trial NCT01189136?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2006-07. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01189136?

The interventions under investigation include: Sham treatment (OTHER), PTNS Active Treatment (DEVICE).

Who is sponsoring clinical trial NCT01189136?

This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01189136's enrollment target sits among peer trials

84 983rd of 2000 higher than 1,011 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01189136, the US trial registry maintained by the National Library of Medicine. NCT01189136 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.